GENESIS BIOPHARMA POLAND SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ

TAX ID5273067313

KRS0001048712

Share capital5,000.00 zł

★ ★ ★ ★ ★ ★ ★ ★ ★ ★

No opinion. Add your first review

address

UL. RONDO IGNACEGO DASZYŃSKIEGO 2B, 00-843 WARSZAWA

Show on map

Is this your company?Update company information to get new customers, get notified of new reviews, and more!

Register Data

Full name

GENESIS BIOPHARMA POLAND SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ

uses securityreCAPTCHA

Privacy – Terms of Use

Legal address

UL. RONDO IGNACEGO DASZYŃSKIEGO 2B, 00-843 WARSZAWA

Show on map

NIP

5273067313

REGON

525915434

KRS

0001048712

Legal form

limited liability company

Register Address

UL. RONDO IGNACEGO DASZYŃSKIEGO 2B, 00-843 WARSZAWA

Date of registration in KRS

2023-07-24

Date of commencement of economic activity

2023-07-24

Act signature

RDF/716288/25/755

Pkd codes

73.20.Z - Market research and public opinion polling

46.46.Z - Wholesale trade of pharmaceutical and medical products

74.90.Z - Other professional, scientific and technical activities, not elsewhere classified

Payer VAT status

Active

Vat list bank account(s)

PL85 1090 2398 0000 0001 5946 9641

PL87 1090 2398 0000 0001 5859 2046

PL65 1090 2398 0000 0001 5792 8089

PL62 1090 2398 0000 0001 5792 9307

PL56 1090 2398 0000 0001 5663 8442

PL54 1090 2398 0000 0001 5432 4446

Show more bank accounts from VAT list (3)

Company authorities

representation authorityMANAGEMENT

representation type

KAŻDY Z CZŁONKÓW ZARZĄDU MA PRAWO REPREZENTOWAĆ SPÓŁKĘ JEDNOOSOBOWO

MANAGEMENT

Christophoros Papachristophorou

Member Of The Board, 40 years old

Alexandros Jacovides

Chairman Of The Board, 71 years old

Constantinos Evripides

Member Of The Board

shareholders

GENESIS PHARMA (CYPRUS) LTD.

100% 100 udziałów o łącznej wartości 5000.00 zł

Financial data

Net sales [PLN]

Gross profit / loss [PLN]

Automatically generated based on financial statements from KRS Registry

	2023	2024
	M PLN	M PLN	%
Profit (loss) on sale	-0	0,1	687,7
Gross profit (loss)	-0	0,1	550,8
Short time liabilities	0	0,2	760,4
Other operating costs	0	0	1 333 933,3
Equity capital	-0	0	307,8
Operating profit (EBIT)	-0	0,1	670,9
Assets	0	0,7	7080,3
Net profit (loss)	-0	0,1	343,2
Cash	0	0,3	5844,8
Net income from sale	0	2,1	-∞
Liabilities and provisions for liabilities	0	0,6	2105,9
Working assets	0	0,7	7080,3
Other income costs	0	0	266,7
	%	%	p.p.
Profitability of capital	126,6	148,1	21,5
Equity capital to total assets	-206,1	6	212,1
Gross profit margin		5
	Days	Days	Days
Short term commitment turnover cycle	2 147 483 648	36	-2 147 483 612

Current financial liquidity indicator	0.37546250224113464	3.133394241333008	2,7